InsidersTradesSigma
Promimic AB: directors' dealings · Finland · FIN-FSA
FI:promimic-ab-36a41dSE0017487242FI·FIN-FSAMcap 225M€Healthcare
Explore the full insider trade history of Promimic AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Promimic AB has published 7 public disclosures. Market capitalisation: €224.8m. The latest transaction was reported on 18 March 2026 — Purchase. Among the most active insiders: Magnus Larsson. The full history is openly available.
7
Insider Decl.
0
Thresholds
€16,185
7 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
11.90 €
Analyst consensus
Income statement
Revenue44.4 M€
Gross profit44.2 M€100% margin
Net income−8.8 M€-17.1% margin
Valuation
P/Book3.8x
Beta-0.39
Balance sheet & cash
Market cap224.8 M€
Free Cash Flow−13.0 M€
Profitability & ownership
ROE-13.6%
ROA-7.2%
% insiders85.2%
% institutions10.4%
Last declaration on 18 March 2026
Declarations7 total
Executives●Purchase26FIN-FSA
€3,0813,000 shares@ €1.02710.0014% mcap33.6% of flow
Aktie
FI:A003X119-1·
Ideal exit: 13 Dec 2026 (T+270)
Executives●Purchase9FIN-FSA
€2,4352,080 shares@ €1.17050.0011% mcap34.7% of flow
Aktie
FI:A003W837-1·
Ideal exit: 30 Nov 2026 (T+270)
Executives●Purchase11FIN-FSA
€2,2681,673 shares@ €1.35580.0010% mcap32.4% of flow
Aktie
FI:A003S118-1·
Ideal exit: 1 Jun 2026 (T+270)
Executives●Purchase26FIN-FSA
€2,6442,000 shares@ €1.3220.0012% mcap28.8% of flow
Aktie
FI:A003R911-1·
Ideal exit: 29 May 2026 (T+270)
Executives●Purchase24FIN-FSA
€2,6141,997 shares@ €1.30910.0012% mcap28.5% of flow
Aktie
FI:A003R829-1·
Ideal exit: 25 May 2026 (T+270)
Executives●Purchase11FIN-FSA
€2,3041,470 shares@ €1.56720.0010% mcap32.9% of flow
Aktie
FI:A003P050-1·
Ideal exit: 21 Feb 2026 (T+270)
Executives●Purchase22FIN-FSA
€838500 shares@ €1.67660.0004% mcap9.1% of flow
Aktie
FI:A003O689-1·
Ideal exit: 15 Feb 2026 (T+270)
7 of 7 declarations